SEDAR Interim Financial Statements

[
  {
    "companyName": "Rapid Dose Therapeutics Corp.",
    "reportingPeriodEnd": "2025-11-30",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cashAndCashEquivalents": [109163, 20717],
      "amountsReceivable": [258873, 302613],
      "inventory": [179369, 247007],
      "prepaidExpenses": [116843, 93388],
      "rightOfUseAsset": [2274888, 0],
      "propertyAndEquipment": [849539, 971224],
      "accountsPayableAndAccruedLiabilities": [4170837, 4230708],
      "notesPayable": [497500, 0],
      "dueToRelatedParties": [196585, 0],
      "securedConvertibleNotes": [3134455, 2609770],
      "currentPortionOfLeaseLiability": [235587, 0],
      "leaseLiability": [2199344, 0],
      "derivedMetrics": {
        "cashPerShare": [0.0008, null],
        "workingCapitalPerShare": [-0.0575, null]
      }
    },
    "incomeStatement": {
      "revenue": [657135, 501689, 2112797, 1416599],
      "costOfSales": [347339, 231355, 1034840, 561565],
      "grossProfit": [309796, 270334, 1077957, 855034],
      "personnel": [383162, 299691, 1142276, 1008529],
      "stockBasedCompensation": [63854, 372313, 273504, 1040950],
      "generalAndAdministrative": [203919, 312837, 557732, 923538],
      "salesAndMarketing": [205411, 209973, 424007, 429779],
      "researchAndDevelopment": [15205, 44086, 20045, 99623],
      "depreciation": [126596, 48160, 395578, 181108],
      "interestAndAccretion": [452163, 347755, 954480, 893934],
      "netComprehensiveLoss": [1140514, 1364481, 2689665, 3722427],
      "weightedAverageSharesOutstanding": 131675200
    },
    "cashFlowStatement": {
      "netComprehensiveLoss": [1140514, 1364481, 2689665, 3722427],
      "stockBasedCompensation": [63854, 372313, 273504, 1040950],
      "accretionExpense": [282239, 252302, 524685, 388277],
      "depreciationAndAmortization": [126596, 48160, 395578, 181108],
      "sharesIssuedForDirectorsFees": [0, 50000, 100000, 100000],
      "sharesIssuedForInterest": [157667, 93775, 344180, 304265],
      "sharesForFeesForExtensionOfNotes": [154522, 0, 154522, 0],
      "changesInNonCashOperatingWorkingCapital": [-266745, -266402, -869444, -1151415],
      "rightOfUseAsset": [0, 0, -2547874, 0],
      "additionsToPropertyAndEquipment": [0, 0, -899, 0],
      "dueToRelatedParties": [196585, -240144, 196585, -206288],
      "notesPayable": [164000, 0, 497500, 0],
      "leaseRightOfUse": [-57174, 0, 2434931, 29144],
      "repaymentOfUnsecuredConvertibleNotes": [0, 0, 0, -100000],
      "issueOfSharesForPrivatePlacement": [0, 474966, 377647, 785355],
      "issueOfSharesAndWarrants": [0, 0, 0, 580532]
    },
    "investmentsAndOtherAssets": [],
    "shareStructure": {
      "authorizedShares": "unlimited",
      "issuedShares": [134819129, 129534817],
      "classesOfShares": ["common shares"],
      "warrants": [
        {
          "number": 27643393,
          "exercisePrice": 0.16,
          "expiryDate": "2026-11-30"
        }
      ],
      "options": [
        {
          "number": 2500000,
          "exercisePrice": 0.15,
          "expiryDate": "2026-02-23"
        },
        {
          "number": 9350000,
          "exercisePrice": 0.18,
          "expiryDate": "2026-04-01"
        },
        {
          "number": 750000,
          "exercisePrice": 0.24,
          "expiryDate": "2026-10-25"
        }
      ],
      "rightsConvertibleInstruments": "Secured convertible notes, convertible at $0.17 per share until November 30, 2026."
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "2025-11-30": {
          "salaries": 112500,
          "shareBasedCompensation": 27125,
          "total": 139675
        },
        "2024-11-30": {
          "salaries": 112500,
          "shareBasedCompensation": 172653,
          "total": 285153
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "Directors",
          "description": "Advances from directors",
          "amount": 196585,
          "period": "2025-11-30"
        },
        {
          "counterparty": "Directors",
          "description": "Interest paid to directors on secured convertible notes",
          "amount": 51309,
          "period": "2025-11-30"
        }
      ]
    },
    "subsequentEvents": [
      {
        "eventDate": "2025-12-02",
        "description": "Repayment of secured promissory note of $50,000",
        "impactValue": 50000
      },
      {
        "eventDate": "2025-12-31",
        "description": "Issued 362,708 common shares at $0.13 per share for $47,154 of monthly interest on secured convertible notes",
        "impactValue": 47154
      }
    ]
  }
]